Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | CTLT | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Catalent Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 145.89 | 336.40 | 58.40 | ||
| High | 148.02 | 340.44 | 58.72 | ||
| Low | 144.35 | 336.32 | 58.29 | ||
| Last | 146.80 | 338.22 | 58.68 | ||
| Change | +0.70 | +1.85 | +0.23 | ||
| % Change | +0.48% | +0.55% | +0.39% | ||
| Volume | 744,700 | 290,200 | 3,004,900 | ||
| 20-Day Average Volume | 668,220 | 454,265 | 1,968,855 | ||
| Previous Close | 146.10 | 336.37 | 58.45 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 143.90 | 325.73 | 57.56 | ||
| 20-Day Raw Stochastic | 76.74% | 83.51% | 98.55% | ||
| 20-Day Relative Strength | 60.33% | 71.16% | 68.21% | ||
| Weighted Alpha | +40.41 | +55.32 | +27.96 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.76% since 07/19/24 | +2.75% since 07/19/24 | +1.33% since 07/19/24 | ||
| Low | 143.97 on 07/24/24 | 325.54 on 07/22/24 | 57.80 on 07/22/24 | ||
| High | 148.88 on 07/22/24 | 343.98 on 07/25/24 | 58.72 on 07/26/24 | ||
| 1-Month | |||||
| %Chg | +8.08% since 06/26/24 | +6.04% since 06/26/24 | +4.49% since 06/26/24 | ||
| Low | 134.03 on 06/27/24 | 309.04 on 07/03/24 | 55.91 on 06/27/24 | ||
| High | 150.39 on 07/16/24 | 343.98 on 07/25/24 | 58.72 on 07/26/24 | ||
| 3-Month | |||||
| %Chg | +7.95% since 04/26/24 | +44.63% since 04/26/24 | +4.94% since 04/26/24 | ||
| Low | 129.33 on 06/20/24 | 233.31 on 04/30/24 | 53.51 on 05/29/24 | ||
| High | 150.39 on 07/16/24 | 343.98 on 07/25/24 | 58.72 on 07/26/24 | ||
| 6-Month | |||||
| %Chg | +3.27% since 01/26/24 | +55.14% since 01/26/24 | +12.35% since 01/26/24 | ||
| Low | 128.00 on 02/07/24 | 208.62 on 02/08/24 | 51.54 on 01/31/24 | ||
| High | 150.39 on 07/16/24 | 343.98 on 07/25/24 | 60.20 on 02/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,703,066 | 14,920,025 | 10,578,281 | ||
| Shares Outstanding, K | 100,637 | 44,356 | 180,980 | ||
| Annual Sales | 1,887,100,000 | 2,327,500,000 | 4,263,000,000 | ||
| Annual Net Income | 249,700,000 | 984,800,000 | -256,000,000 | ||
| Last Quarter Sales | 515,300,000 | 677,700,000 | 1,074,000,000 | ||
| Last Quarter Net Income | 43,400,000 | 306,600,000 | -101,000,000 | ||
| 60-Month Beta | 0.37 | 0.55 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 05/01/24 | 6.17 on 05/01/24 | -0.06 on 05/08/24 | ||
| Latest Earnings Date | 08/01/24 | 07/31/24 | 09/03/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.19 | 15.68 | 0.00 | ||